IVIMTechnology Co., Ltd. engages in the development of solutions for simultaneous imaging of cells and bio-drugs that compose various tissues and organs inside a living organism. Its products include IVM-C3, IVM-M3, IVM-CM3, and IVM-MS3. The company was founded by Kim Pil-Han and Kim In-Sun on June 23, 2017 and is headquartered in Daejeon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company